Biomarker Analysis Using the Simple Western Advances Pathogen Identification and Cancer Research

This presentation is now available to view on-demand

Biomarker discovery relies on the specific and accurate detection of protein targets that play key roles in regulatory response of pathogens as well as disease states in cancer cells and tissues. Immunodetection by Western blot analysis is a widely used technique to identify biomarkers involved in pathogen expression and cancer translational research. This technique has its challenges, namely unreliable data, semi-quantitative results, delayed time to results, reduced productivity and ultimately more costly research programs. ProteinSimple has introduced the Simple Western™, a novel capillary electrophoresis (CE) based immunodetection platform for protein separation by size or charge and characterization. It addresses the major challenges that researchers face with the traditional western blot. The Simple Western is a complete automated walk-away solution that is a gel-free, blot-free, and hands-free. In this webinar, participants will describe a range of applications utilizing the Simple Western technology. These applications address identification and characterization of emerging pathogens, and detection and quantitation of a key biomarker involved in acute lymphoblastic leukemia.

In this webinar you will learn:

  • How key targets involved in pathogen expression are characterized by both size - and charge - based separation on the Simple Western
  • How to quantitatively analyze key biomarker proteins in a diverse array of cancer cell types using the Simple Western
  • How the Simple Western platform integrates and automates all manual operations associated with Western blotting
  • How the Simple Western automated platform can generate up to 96 assays in one experiment with great precision and reproducibility

Who Should Attend

  • Protein biochemists
  • Life science researchers
  • Therapeutics protein developers
  • Molecular biologists
  • Protein-based vaccine developers
  • Oncology drug developers
  • Research oncologists

Research Areas
Proteomics, protein science, clinical pathology, cancer translational research, biochemistry, metabolomics, pharmacology, biotherapeutic processing

Pharma industry, biotech, government, healthcare providers (hospitals, clinics), academia and contract laboratories


John Proctor, Ph. D
Director, Corporate Development
Protein Simple
Philip Lorenzi Ph.D.
Supervisor of Lab & Research
MD Anderson Cancer Center
View Bio
David Hirschberg Ph.D.
Assistant Prof. of Clinical Pathology
Columbia University
View Bio
Bart Wacek
Executive Publisher
Journal of Molecular Biology

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) required fields